Search results for: Health Policy and Regulation
Filter search results
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
…discussed innovative study designs and analysis methods, critical challenges regarding heterogeneity and uncertainty from the perspective of health economics and HTA. He noted the emergence of new and innovative study…
OHE’s submission for the DHSC’s next 10 years of planning
9 December 2024
…consider how scarce resources are allocated in already over-stretched and under-funded health care systems. Choices and trade-offs in healthcare are literally a matter of health and death. Within this paradigm,…
Around the World in HTAs: United States – Making HTA Great Again
11 June 2024
A primer on US health care The US’s health care system is notable for its contrast with that of other high-income countries. Most notably, the US lacks universal health coverage….
Understanding the preferences of people with acute leukemia for different health outcomes
25 September 2025
…studies and health policy decisions take patient priorities into account. This research paper, Understanding the preferences of people with acute leukemia for different health outcomes, was commissioned and funded by the Acute Leukemia…
The cost of inaction on LDL cholesterol
24 June 2026
…for health systems is straightforward: given the substantial but avoidable health and economic burdens of ASCVD, there is a clear imperative for better prevention and management of elevated LDL-C. Where…
Valuing patient and carer time in HTA: equity and opportunity cost
15 May 2026
…carer time are inputs to healthcare just as much as physician and nursing time. As such, trade-offs between time and health are no different from trade-offs between money and health….
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
…in the UK and the US were, respectively, 20 and 54 percent above the EEC average, whereas those in France and Italy were, respectively, 30 and 28 percent below the…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…and involve patients and their healthcare professionals to ensure that the development and implementation of LA therapies align with patient needs, health system improvements, and societal or economic goals. The…
The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?
22 May 2020
The colossal health and economic shock caused by COVID-19 has highlighted the vital role that the public and private sectors play in finding health solutions and producing them in massive…